Phase II study of gemcitabine and split-dose cisplatin plus pembrolizumab as neoadjuvant therapy prior to radical cystectomy (RC) in patients with muscle-invasive bladder cancer (MIBC).

被引：3
|
作者：
Rose, Tracy L. [1 ,2 ]
Harrison, Michael Roger [3 ]
Deal, Allison Mary [2 ]
Osterman, Chelsea K. [4 ]
Ramalingam, Sundhar [5 ]
Whang, Young E. [6 ]
Brower, Blaine Y. [7 ]
Bjurlin, Marc [6 ]
Smith, Angela B. [6 ]
Nielsen, Matthew E. [6 ]
Tan, Hung-Jui [6 ]
Wallen, Eric M. [6 ]
George, Daniel J. [3 ]
Zhang, Tian [3 ]
Drier, Anthony [6 ]
Kim, William Y. [2 ]
Milowsky, Matthew, I [7 ]
机构：
[1] Univ N Carolina, Sch Med, Chapel Hill, NC 27515 USA
[2] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[3] Duke Univ, Duke Canc Inst, Ctr Prostate & Urol Canc, Durham, NC USA
[4] Univ N Carolina, Dept Med, Div Oncol, Chapel Hill, NC 27515 USA
[5] Duke Canc Inst, Durham, NC USA
[6] Univ N Carolina, Chapel Hill, NC 27515 USA
[7] Univ N Carolina, Dept Med, Div Hematol Oncol, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.396
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
396
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II Study of Gemcitabine and Split-Dose Cisplatin Plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer
    Rose, Tracy L.
    Harrison, Michael R.
    Deal, Allison M.
    Ramalingam, Sundhar
    Whang, Young E.
    Brower, Blaine
    Dunn, Mary
    Osterman, Chelsea K.
    Heiling, Hillary M.
    Bjurlin, Marc A.
    Smith, Angela B.
    Nielsen, Matthew E.
    Tan, Hung-Jui
    Wallen, Eric
    Woods, Michael E.
    George, Daniel
    Zhang, Tian
    Drier, Anthony
    Kim, William Y.
    Milowsky, Matthew I.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (28) : 3140 - +
  • [2] Re: Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer
    Laukhtina, Ekaterina
    Shariat, Shahrokh F.
    [J]. EUROPEAN UROLOGY, 2022, 82 (02) : 242 - 243
  • [3] A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC)
    Xu, Abai
    Xu, Peng
    Chen, Chunxiao
    Liu, Zhe
    Jiang, Ning
    Bi, Enguang
    Cao, Manming
    Chen, BinShen
    Liu, Chunxiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Neoadjuvant pembrolizumab for cisplatin-ineligible muscle-invasive bladder cancer prior to radical cystectomy.
    Rose, Kyle M.
    Bandini, Marco
    Huelster, Heather L.
    Basile, Giuseppe
    Naidu, Shreyas U.
    Spiess, Philippe E.
    Necchi, Andrea
    Li, Roger
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [5] Phase II trial of neoadjuvant nivolumab with cisplatin and gemcitabine in muscle-invasive bladder cancer patients undergoing radical cystectomy.
    Gupta, Shilpa
    Agarwal, Neeraj
    Konety, Badrinath R.
    Weight, Christopher J.
    Thyagarajan, Bharat
    Murugan, Paari J.
    Koopmeiners, Joseph S.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
    Kaneko, Gou
    Kikuchi, Eiji
    Matsumoto, Kazuhiro
    Obata, Jun
    Nakamura, So
    Miyajima, Akira
    Oya, Mototsugu
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
  • [7] Biologic activity of dasatinib administered as neoadjuvant therapy preceding radical cystectomy (RC) for muscle-invasive bladder cancer (MIBC)
    Knudsen, Beatrice
    Hahn, Noah M.
    Daneshmand, Siamak
    Posadas, Edwin M.
    Muhanty, Sambit
    Lerner, Seth P.
    Sonpavde, Guru
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [8] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [9] Re: Ekaterina Laukhtina, Shahrokh F. Shariat. Phase II Study of Gemcitabine and Split-dose Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol. 2022;82:242-3
    Takahashi, Takeshi
    [J]. EUROPEAN UROLOGY, 2022, 82 (04) : E107 - E108
  • [10] Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder
    Chaudhary, U. B.
    Golshayan, A. R.
    Brisendine, A.
    Kraft, A. S.
    Clarke, H.
    Keane, T. E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345